REPLICEL LIFE SCIENCES INC. Directors Remuneration Expense
REPLICEL LIFE SCIENCES INC. reported Directors Remuneration Expense of CAD 79.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DirectorsRemunerationExpense · last filed 2023-05-02
| Period end | Directors Remuneration Expense 12 month |
|---|---|
| 2022-12-31 | 79.00K CAD 20-F · filed 2023-05-02 |
| 2021-12-31 | 75.08K CAD 20-F · filed 2023-05-02 |
| 2020-12-31 | 71.25K CAD 20-F · filed 2023-05-02 |
| 2019-12-31 | 70.50K CAD 20-F/A · filed 2022-09-13 |
| 2018-12-31 | 54.75K CAD 20-F · filed 2021-05-17 |
| 2017-12-31 | 55.00K CAD 20-F/A · filed 2021-03-31 |
| 2016-12-31 | 55.00K CAD 20-F · filed 2019-04-30 |
| 2015-12-31 | 42.14K CAD 20-F · filed 2018-05-11 |